Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach

OBJECTIVES: One way to optimize the drug prescription in rheumatoid arthritis (RA) is to identify predictive biomarkers of drug responsiveness. Here, we investigated the potential "theranostic" value of proteins of the S100 family by monitoring levels of both S100A8 and S100A9 in blood sam...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Obry, Antoine, Lequerré, Thierry, Hardouin, Julie, Boyer, Olivier, Fardellone, Patrice, Philippe, Peggy, Le Loët, Xavier, Cosette, Pascal, Vittecoq, Olivier
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4278766/
https://ncbi.nlm.nih.gov/pubmed/25546405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0115800
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars